Magic mushroom compound tested for cocaine addiction safety
NCT ID NCT06102434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a single 25 mg dose of psilocybin (the active ingredient in magic mushrooms) can be safely given to people with cocaine use disorder who want to quit. Ten adults from Los Angeles will take the drug in a comfortable room with two clinicians present, and their heart rate, blood pressure, and mood will be checked for six hours. Researchers will also follow up remotely for 90 days to monitor any lasting effects. The goal is to see if psilocybin is safe enough to study further as a treatment for cocaine addiction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Brain scans reveal how stress fuels cocaine relapse
- Scientists scan brains of cocaine users to uncover dopamine secrets
- Sound waves against addiction: ultrasound zaps cocaine cravings
- Magic mushroom compound tested to help people quit cocaine
- New drug tested against cocaine: no cure, just safety check